Replimune Group Ownership | Who Owns Replimune Group?

Replimune Group Ownership Summary

Replimune Group is owned by 103.53% institutional investors, 1.75% insiders. Baker bros. advisors lp is the largest institutional shareholder, holding 11.90% of REPL shares. State Street® SPDR® S&P® Biotech ETF is the top mutual fund, with 3.22% of its assets in Replimune Group shares.

REPL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Replimune Group	103.53%	1.75%	-5.28%
Sector	Healthcare Stocks	245.07%	12.10%	-157.17%
Industry	Biotech Stocks	380.48%	11.73%	-292.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Baker bros. advisors lp	11.05M	11.90%	$122.27M
Blackrock funding, inc. /de	8.96M	9.65%	$99.17M
Rtw investments, lp	7.41M	7.99%	$82.05M
Ridgeback capital investments	7.31M	7.88%	$80.93M
Blackrock	4.71M	7.08%	$42.42M
Goldman sachs group	4.54M	4.89%	$50.27M
State street	4.44M	4.78%	$49.15M
Suvretta capital management	4.39M	4.73%	$48.60M
Boxer capital management	3.98M	4.29%	$44.09M
Vanguard group	3.78M	4.10%	$36.70M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Ridgeback capital investments	7.31M	100.00%	$80.93M
Fcpm iii services b.v.	2.81M	4.14%	$31.09M
Boxer capital management	3.98M	3.32%	$44.09M
Opaleye management	1.38M	1.39%	$15.33M
Ghost tree capital	450.00K	1.27%	$4.05M
Logos global management lp	2.50M	1.19%	$27.68M
Sofinnova investments	1.81M	1.03%	$16.78M
Suvretta capital management	4.39M	0.89%	$48.60M
Boxer capital	1.54M	0.73%	$13.83M
Rtw investments, lp	7.41M	0.70%	$82.05M

Top Buyers

Holder	Shares	% Assets	Change
Ridgeback capital investments	7.31M	100.00%	7.31M
Boxer capital management	3.98M	3.32%	2.81M
Blackrock funding, inc. /de	8.96M	0.00%	2.72M
Logos global management lp	2.50M	1.19%	2.50M
Braidwell lp	2.75M	0.34%	2.33M

Top Sellers

Holder	Shares	% Assets	Change
Price t rowe associates inc /md/	1.62M	0.00%	-6.50M
Atlas venture life science advisors	-	-	-2.10M
Commodore capital lp	-	-	-1.43M
Rosalind advisors	-	-	-1.41M
Camber capital management lp	-	-	-1.35M

New Positions

Holder	Shares	% Assets	Change	Value
Ridgeback capital investments	7.31M	100.00%	7.31M	$80.93M
Logos global management lp	2.50M	1.19%	2.50M	$27.68M
Boxer capital	1.54M	0.73%	1.54M	$13.83M
Opaleye management	1.38M	1.39%	1.38M	$15.33M
Artisan partners limited partnership	973.50K	0.02%	973.50K	$10.78M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-8.00
Global retirement partners	-32.00
Root financial partners	-32.00
Creative financial designs inc /adv	-33.00
Stephens consulting	-35.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	225	8.70%	96,084,260	18.48%	103	1.34%	147	33.64%	46	-16.36%
Mar 31, 2026	65	-64.67%	10,497,436	-86.84%	11	0.15%	32	-65.59%	18	-67.86%
Dec 31, 2025	102	-46.32%	28,686,776	-65.39%	31	0.38%	51	-52.34%	33	-31.25%
Sep 30, 2025	187	3.89%	82,873,954	6.75%	90	1.26%	105	25.00%	48	-20.00%
Jun 30, 2025	189	13.17%	80,918,624	7.29%	88	1.08%	86	-2.27%	65	35.42%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
State Street® SPDR® S&P® Biotech ETF	2.70M	3.22%	6.21K
Vanguard US Total Market Shares ETF	2.02M	2.63%	478.00K
iShares Russell 2000 ETF	2.03M	2.41%	-36.00K
Vanguard Total Stock Mkt Idx Inv	1.97M	2.35%	-
Vanguard MStar Total Stk Mkt Idx Invest	1.97M	2.35%	-
Vanguard Morn Total Stk Mkt Idx Investor	1.97M	2.35%	-
T. Rowe Price Integrated US Sm Gr Eq	1.60M	1.94%	-
T. Rowe Price Integrated US SmCapGrEq	1.60M	1.94%	-
T. Rowe Price Health Sciences	1.43M	1.73%	-91.78K
T. Rowe Price New Horizons Tr-Z	1.28M	1.66%	1.80K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 17, 2026	Hill Emily Luisa	Chief Financial Officer	Sell	$132.18K
Aug 10, 2026	Patel Sushil	Chief Executive Officer	Sell	$510.25K
Aug 10, 2026	Hill Emily Luisa	Chief Financial Officer	Sell	$148.48K
Aug 10, 2026	Xynos Konstantinos	Chief Medical Officer	Sell	$148.47K
Aug 10, 2026	Schwendenman Andrew	Chief Accounting Officer	Sell	$98.99K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	2	5
2026 Q2	-	8
2026 Q1	-	-
2025 Q4	-	4
2025 Q3	-	1

REPL Ownership FAQ

Who Owns Replimune Group?

Replimune Group shareholders are primarily institutional investors at 103.53%, followed by 1.75% insiders and -5.28% retail investors. The average institutional ownership in Replimune Group's industry, Biotech Stocks , is 380.48%, which Replimune Group falls below.

Who owns the most shares of Replimune Group?

Replimune Group’s largest shareholders are Baker bros. advisors lp (11.05M shares, 11.90%), Blackrock funding, inc. /de (8.96M shares, 9.65%), and Rtw investments, lp (7.41M shares, 7.99%). Together, they hold 29.54% of Replimune Group’s total shares outstanding.

Does Blackrock own Replimune Group?

Yes, BlackRock owns 7.08% of Replimune Group, totaling 4.71M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 42.42M$. In the last quarter, BlackRock increased its holdings by 101.23K shares, a 2.19% change.

Who is Replimune Group’s biggest shareholder by percentage of total assets invested?

Ridgeback capital investments is Replimune Group’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 7.31M Replimune Group shares, valued at 80.93M$.

Who is the top mutual fund holder of Replimune Group shares?

State Street® SPDR® S&P® Biotech ETF is the top mutual fund holder of Replimune Group shares, with 3.22% of its total shares outstanding invested in 2.7M Replimune Group shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools